Georgia R. Gore-Langton

Georgia R. Gore-Langton

Auto-generated profile, based on publicly available information

Georgia R. Gore-Langton

Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2020 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
LDLouise Tina Day
Louise Tina Day
GGGeorgia R. Gore-Langton
Georgia R. Gore-Langton
ARAhmed Ehsanur Rahman
Ahmed Ehsanur Rahman
OBOmkar Basnet
Omkar Basnet
JSJosephine Shabani
Josephine Shabani
JLJoy E. Lawn
Joy E. Lawn
Background: Countries with the highest burden of maternal and newborn deaths and stillbirths often have little information on these deaths. Since over 81% of births worldwide now occur in facilities, using routine facility data could reduce this data gap. We assessed the availability, quality, and utility of routine labour and delivery ward register data in five hospitals in Bangladesh, Nepal, and Tanzania. This paper forms the baseline register assessment for the Every Newborn-Birth Indicators Research Tracking in Hospitals (EN-BIRTH) study. Methods: We extracted 21 data elements from routine hospital labour ward registers, useful to calculate selected maternal and newborn health (MNH) indicators. The study sites were five public hospitals during a one-year period (2016–17). We measured 1) availability: completeness of data elements by register design, 2) data quality: implausibility, internal consistency, and heaping of birthweight and explored 3) utility by calculating selected MNH indicators using the available data. Results: Data were extracted for 20,075 births. Register design was different between the five hospitals with 10–17 of the 21 selected MNH data elements available. More data were available for health outcomes than interventions. Nearly all available data elements were > 95% complete in four of the five hospitals and implausible values were rare. Data elements captured in specific columns were 85.2% highly complete compared to 25.0% captured in non-specific columns. Birthweight data were less complete for stillbirths than live births at two hospitals, and significant heaping was found in all sites, especially at 2500g and 3000g. All five hospitals recorded count data required to calculate impact indicators including; stillbirth rate, low birthweight rate, Caesarean section rate, and mortality rates. Conclusions: Data needed to calculate MNH indicators are mostly available and highly complete in EN-BIRTH study hospital routine labour ward registers in Bangladesh, Nepal and Tanzania. Register designs need to include interventions for coverage measurement. There is potential to improve data quality if Health Management Information Systems utilization with feedback loops can be strengthened. Routine health facility data could contribute to reduce the coverage and impact data gap around the time of birth.

9 November 2022 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
GGGeorgia R Gore-Langton
Georgia R Gore-Langton
Jorge CanoJorge Cano
Jorge Cano
HSHope Simpson
Hope Simpson
ATAndrew Tatem
Andrew Tatem
NTNatalia Tejedor-Garavito
Natalia Tejedor-Garavito
RCR. Matthew Chico
R. Matthew Chico
Background: Women are at risk of severe adverse pregnancy outcomes attributable to Plasmodium spp. infection in malaria-endemic areas. Malaria control efforts since 2000 have aimed to reduce this burden of disease. Methods: We used data from the Malaria Atlas Project and WorldPop to calculate global pregnancies at-risk of Plasmodium spp. infection. We categorised pregnancies as occurring in areas of stable and unstable P. falciparum and P. vivax transmission. We further stratified stable endemicity as hypo-endemic, meso-endemic, hyper-endemic, or holo-endemic, and estimated pregnancies at risk in 2000, 2005, 2010, 2015, 2017, and 2020. Findings: In 2020, globally 120.4M pregnancies were at risk of P. falciparum, two-thirds (81.0M, 67.3%) were in areas of stable transmission; 85 2M pregnancies were at risk of P. vivax, 93.9% (80.0M) were in areas of stable transmission. An estimated 64.6M pregnancies were in areas with both P. falciparum and P. vivax transmission. The number of pregnancies at risk of each of P. falciparum and P. vivax worldwide decreased between 2000 and 2020, with the exception of sub-Saharan Africa, where the total number of pregnancies at risk of P. falciparum increased from 37 3M in 2000 to 52 4M in 2020. Interpretation: Historic investments in malaria control have reduced the number of women at risk of malaria in pregnancy in all endemic regions except sub-Saharan Africa. Population growth in Africa has outpaced reductions in malaria prevalence. Interventions that reduce the risk of malaria in pregnancy are needed as much today as ever.

27 July 2023 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
GMGeorge Mtove
George Mtove
RCR. Matthew Chico
R. Matthew Chico
MMMadanitsa Madanitsa
Madanitsa Madanitsa
HBHellen C. Barsosio
Hellen C. Barsosio
OMOmari Abdul Msemo
Omari Abdul Msemo
CSChristentze Schmiegelow
Christentze Schmiegelow
Malaria and sexually transmitted and reproductive tract infections (STIs/RTIs) are highly prevalent in sub-Saharan Africa and associated with poor pregnancy outcomes. We investigated the individual and combined effects of malaria and curable STIs/RTIs on fetal growth in Kenya, Tanzania, and Malawi. This study was nested within a randomized trial comparing monthly intermittent preventive treatment for malaria in pregnancy with sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine, alone or combined with azithromycin. Fetal weight gain was assessed by serial prenatal ultrasound. Malaria was assessed monthly, and Treponema pallidum, Neisseria gonorrhoeae, Trichomonas vaginalis, Chlamydia trachomatis and bacterial vaginosis at enrolment and in the third trimester. The effect of malaria and STIs/RTIs on fetal weight/birthweight Z-scores was evaluated using mixed-effects linear regression. 1,435 pregnant women had fetal/birth weight assessed 3,950 times. Compared to women without malaria or STIs/RTIs (n=399), malaria-only (n=267), STIs/RTIs-only (n=410) or both (n=353) were associated with reduced fetal growth (adjusted mean difference in fetal/birth weight Z-score [95% CI]: malaria=-0.18 [-0.31,-0.04], p=0.01]; STIs/RTIs=-0.14 [-0.26,-0.03], p=0.01]; both=-0.20 [-0.33,-0.07], p=0.003). Paucigravidae experienced the greatest impact. Malaria and STIs/RTIs are associated with poor fetal growth especially among paucigravidae women with dual infections. Integrated antenatal interventions are needed to reduce the burden of both malaria and STIs/RTIs.

1 June 2020 in Tropical Medicine & International Health
Verified
Journal Article
Open access
PDF file
GGGeorgia R. Gore‐Langton
Georgia R. Gore‐Langton
MCMatthew Cairns
Matthew Cairns
YCYves Daniel Compaoré
Yves Daniel Compaoré
ISIssaka Sagara
Issaka Sagara
IKIrene Kuepfer
Irene Kuepfer
JOJean Bosco Ouedraogo
Jean Bosco Ouedraogo
Objectives Mass administration of azithromycin has reduced mortality in children in sub-Saharan Africa but its mode of action is not well characterised. A recent trial found that azithromycin given alongside seasonal malaria chemoprevention was not associated with a reduction in mortality or hospital admissions in young children. We investigated the effect of azithromycin on the nutritional status of children enrolled in this study. Methods A total of 19 578 children in Burkina Faso and Mali were randomised to receive either azithromycin or placebo alongside seasonal malaria chemoprevention with sulfadoxine-pyrimethamine plus amodiaquine monthly for three malaria transmission seasons (2014-2016). After each transmission season, anthropometric measurements were collected from approximately 4000 randomly selected children (2000 per country) at a cross-sectional survey and used to derive nutritional status indicators. Binary and continuous outcomes between treatment arms were compared by Poisson and linear regression. Results Nutritional status among children was poor in both countries with evidence of acute and chronic malnutrition (24.9-33.3% stunted, 15.8-32.0% underweight, 7.2-26.4% wasted). There was a suggestion of improvement in nutritional status in Burkina Faso and deterioration in Mali over the study period. At the end of each malaria transmission season, nutritional status of children did not differ between treatment arms (seasonal malaria chemoprevention plus azithromycin or placebo) in either the intention-to-treat or per-protocol analyses (only children with at least three cycles of SMC in the current intervention year). Conclusions The addition of azithromycin to seasonal malaria chemoprevention did not result in an improvement of nutritional outcomes in children in Burkina Faso and Mali.

18 September 2024 in BMJ Public Health
Verified
Journal Article
Open access
PDF file
GGGeorgia R Gore-Langton
Georgia R Gore-Langton
MMMadanitsa Madanitsa
Madanitsa Madanitsa
HBHellen C Barsosio
Hellen C Barsosio
DMDaniel T R Minja
Daniel T R Minja
JMJacklin Mosha
Jacklin Mosha
RCR. Matthew Chico
R. Matthew Chico
Objectives: Malaria and curable sexually transmitted and reproductive tract infections (STIs/RTIs) are associated with adverse pregnancy outcomes. This study reports the prevalence and risk factors of curable STIs/RTIs, STI/RTI co-infection and STI/RTI and malaria co-infection among HIV-negative pregnant women at their first antenatal care visit in Kenya, Malawi and Tanzania.Methods: HIV-negative pregnant women of all gravidae (n=4680) were screened for syphilis with point-of-care tests and treated if positive. Separately, women provided blood samples (n=4569) for rapid plasma reagin (RPR) testing; positive cases were confirmation byTreponema pallidumparticle agglutination (TPPA). Women also provided dried blood spots for batch testing of malaria by retrospective polymerase chain reaction (PCR (n=4226) methods. A randomly selected subgroup of women provided vaginal swabs for chlamydia, gonorrhoea and trichomoniasis testing by retrospective PCR batch testing (n=1431), and bacterial vaginosis diagnosis by Nugent scoring (n=1402).Results: Malaria prevalence was 14.6% (95% CI 13.6 to 15.7), 45.9% (43.4 to 48.4) of women were positive for at least one curable STI/RTI and 6.7% (5.5 to 8.1) were co-infected with malaria and a curable STI/RTI. Prevalence of individual STIs/RTIs ranged from 28.5% (26.2 to 30.9) for bacterial vaginosis to 14.5% (12.7 to 16.4) for trichomoniasis, 13.8% (12.1 to 15.7) for chlamydia, 2.7% (1.9 to 3.6) for gonorrhoea and 1.7% (1.4 to 2.2) for RPR/TPPA-confirmed syphilis. The prevalence of STI/RTI co-infection was 10.1% (8.7 to 11.8). Paucigravidae, at highest risk of malaria, were also at greater risk of having chlamydia, gonorrhoea and bacterial vaginosis than multigravidae.Conclusions: Of women infected with malaria, 49.0% also had a curable STI/RTI and one in five women with at least one STI/RTI were co-infected with more than one STI/RTI. Current antenatal interventions that address malaria and curable STIs/RTIs remain suboptimal. New approaches to preventing and managing these infections in pregnancy are urgently needed.Trial registration number: NCT03208179.

2 July 2025 in BMC Public Health
Verified
Journal Article
Open access
PDF file
GGGeorgia R. Gore-Langton
Georgia R. Gore-Langton
KMKathryn E. Mansfield
Kathryn E. Mansfield
PRPrithvee Ravi
Prithvee Ravi
ADArrisonia Doubatty
Arrisonia Doubatty
SASuvarna Alladi
Suvarna Alladi
CWCharlotte Warren-Gash
Charlotte Warren-Gash
Introduction: Infections may be associated with an increased risk of poor brain health and frailty among older people, but evidence from low-and-middle-income countries (LMICs) is limited. We aimed to investigate associations between nine infections and cognition, depression, and frailty in India. Methods: We conducted a cross-sectional study using data from Wave 1 (2017–2019) of the Longitudinal Aging Study in India (LASI) survey of adults (≥ 45years) from 35 of India’s 36 states and union territories. Data were collected via face-to-face interviews and direct health measurements. We investigated the association between nine infections, either self-reported ever (periodontal disease) or in the two years before interview (jaundice/hepatitis, malaria, tuberculosis, typhoid, chikungunya, diarrhoea/gastroenteritis, dengue, urinary tract infection [UTI]), and measured global cognitive function, depression, and frailty. We used survey-weighted multivariable logistic regression to compare odds of impaired cognition, depression, and frailty in people with and without infections, overall and for individual infections. Results: We included 64,682 respondents; median age 59 years (IQR:50–67), 53.5% female, 35% reported at least one infection. After controlling for demographic, social/environmental and lifestyle factors, and chronic health conditions, we saw evidence of associations between infection and both depression (OR: 1.28 [95%CI: 1.22–1.35]) and frailty (OR: 1.74 [95%CI: 1.65–1.84]). UTIs were associated with the highest odds of both depression (OR: 1.33 [95%CI: 1.14, 1.55) and frailty (OR: 2.94 [95%CI: 2.51, 3.44]). Reporting at least one infection was associated with reduced odds of impaired cognition (OR: 0.80 [95%CI: 0.74–0.86]). Conclusions: Our results suggest infections are associated with increased depression and frailty in adults over 45 in India. Our finding of association between reported infections and better cognition, is potentially explained by preferential infection recall in those with better cognition. Longitudinal studies are needed to investigate potential causal links between infections and adverse brain health and frailty and guide interventions to improve the health of older people in India and other LMICs.